Baseline characteristics | All groups | Active group | Placebo group |
---|---|---|---|
Number of participants | 29 | 19 | 10 |
Age range (years) | 5–71 | 5–71 | 13–51 |
Adult/child | 23/6 | 14/5 | 9/1 |
Age mean (years); SD | 31.7 ± 17.9 | 27.63 ± 18.6 | 39.4 ± 13.5 |
Adults | 38.6 ± 14.8 | 38 ± 15.8 | 42.3 ± 10.85 |
Children | 10.25 ± 3.5 | 9.9 ± 3.6 | 13 ± n/a |
Sex (female/male) | 15/14 | 10/9 | 5/5 |
Ethnicity: | Â | Â | Â |
White British | 20/29 (69%) | 12/19 (64%) | 8/10 (80%) |
Mixed | 1/29 (3.5%) | 1/19 (5%) | None |
Black/Black Caribbean | 2/29 (7%) | 2/19 (11%) | None |
Indian | 2/29 (7%) | 1/19 (5%) | 1/10 (10%) |
Pakistani | 1/29 (3.5%) | 1/19 (5%) | None |
Asian | 2/29 (7%) | 1/19 (5%) | 1/10 (10%) |
Other ethnic group | 1/29 (3.5%) | 1/19 (5%) | None |
Duration of vitiligo (years) | Â | Â | Â |
Mean ± SD (min; max) | 12.28 ± 9.67 (min = 2; max = 33) | 11.36 ± 10.12 (min = 2; max = 33) | 14.01 ± 8.5 (min = 5; max = 28) |
Vitiligo activity per participant (overall) | Â | Â | Â |
Stable | 6 | 3 | 3 |
Spreading | 19 | 14 | 5 |
Repigmenting | 4 | 2 | 2 |
BSA% covered by vitiligo Mean ± SD (min; max) | 8.83 ± 6.19 (min = 2; max = 25) | 9.84 ± 5.96 (min = 3; max = 25) | 6.9 ± 6.17 (min = 2; max = 21) |
Number of lesions | 84 | 56 | 28 |